10,653€
1,26%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid:
Ask:
Echtzeit-Chart der Astellas Pharma Inc. Aktie
Börsenkurse Astellas Pharma Inc.
| Börse Stuttgart | - | - | - | - | 10,848€ | -0,57% |
| Tradegate | - | - | - | - | 10,728€ | -0,92% |
| Lang & Schwarz | - | - | - | - | 10,803€ | -0,21% |
| Echtzeit Euro | - | - | - | - | 10,848€ | -0,25% |
| Börse Frankfurt | - | - | - | - | 10,653€ | 1,26% |
| gettex | - | - | - | - | 10,778€ | -1,01% |
Profil der Astellas Pharma Inc. Aktie
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.